![]() |
市場調查報告書
商品編碼
2106354
2034年情緒提升機能性食品市場預測-按產品類型、功能成分、健康益處、通路、最終用戶和地區分類的全球分析Mood Enhancement Functional Foods Market Forecasts to 2034 - Global Analysis By Product Type, Functional Ingredient, Health Benefit, Distribution Channel, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球改善情緒的機能性食品市場規模將達到 54 億美元,並在預測期內以 10.8% 的複合年成長率成長,到 2034 年將達到 100 億美元。
改善情緒的機能性食品是指透過添加生物活性成分來支持心理健康的食品和飲料,這些成分能夠影響神經傳導物質活性、壓力反應路徑和情緒調節。這些產品含有益生菌、適應原、ω-3脂肪酸、維生素、礦物質、植物萃取物和胺基酸等功能性成分,這些成分已被證明可以影響血清素、多巴胺和皮質醇水平。它們旨在作為日常飲食的一部分定期食用,包括機能飲料、營養棒、強化乳製品、零食、穀物和糖果甜點。改善情緒的機能性食品的研發是基於臨床研究,這些研究表明,特定的營養素和植物化合物能夠顯著改善情緒、壓力耐受力、認知功能和情緒平衡。
心理健康意識
隨著心理健康在全球範圍內被公認為整體健康的重要組成部分,人們對改善情緒的機能性食品的需求顯著成長。消費者越來越傾向於透過飲食干預等非藥物方法來管理壓力、焦慮和情緒波動。支持腸腦軸連結的研究推動了人們對益生菌和益生元製劑的興趣,這些製劑旨在促進情緒健康。職場健康計畫也開始將機能性食品的推薦納入員工綜合健康計畫中。這種「食療」理念日益被社會接受,正在各個年齡層中創造永續的市場需求。
對有效性的懷疑
消費者和醫療保健專業人士對情緒改善食品功效的質疑限制了市場發展。許多消費者質疑食品中的功能性成分是否能產生與膳食補充劑或藥品相當的療效。安慰劑效應使消費者報告的效果難以解讀,從而削弱了其可信度。主要市場的法律規範限制了某些與情緒相關的健康聲明,阻礙了市場差異化。為了應對這些信任和溝通方面的挑戰,品牌需要大力投資臨床證據,並確保成分訊息的透明度。
個人化營養平台
將情緒調節機能性食品、數位健康平台和個人化營養服務結合,為創新市場拓展提供了契機。基因檢測和微生物組分析能夠識別影響情緒調節的個體營養素缺乏情況,從而實現精準的產品推薦。追蹤情緒模式和飲食攝取的行動應用程式,為數據驅動的個人化服務創造了機會。根據壓力傾向和情緒健康目標量身定做的訂閱式個人化機能性食品盒,可以高價出售。由此可見,食品科技與數位健康的融合正在創造差異化的價值提案。
監理標籤限制
食品中與情緒相關的健康聲明受到嚴格的監管限制,這對市場溝通和消費者教育工作構成了重大威脅。美國食品藥物管理局(FDA)和歐洲食品安全局(EFSA)在食品和藥品分類之間劃定了嚴格的界限,限制了與治療或預防精神健康狀況相關的聲明。品牌必須遵守複雜的實質要求才能做出任何暗示情緒影響的聲明。監管機構對不合規聲明的執法行動可能導致產品召回和聲譽損害。這些限制使得機能性食品生產商難以有效傳達其產品的價值。
新冠疫情帶來了前所未有的壓力、隔離和焦慮,顯著提升了消費者對情緒改善機能性食品的需求。封鎖期間,特殊功能性原料的供應鏈中斷,導致產品暫時短缺。然而,這場危機也促使消費者尋求易於在家中實施的自我護理策略,加速了以食物為基礎的健康習慣的普及。疫情結束後,大眾對心理健康的關注度不斷提高,促使人們更加重視透過飲食來積極管理情緒健康。這種對整體健康的持續關注,不斷推動情緒改善配方的創新。
在預測期內,機能飲料細分市場預計將佔據最大的市場佔有率。
預計在預測期內,機能飲料細分市場將佔據最大的市場佔有率,這主要得益於液體飲料飲用的便利性以及消費者全天飲用飲料的既定習慣。機能飲料使消費者能夠以易於飲用和攜帶的形式精準攝取諸如適應原、L-茶氨酸和B群維生素等改善情緒的成分。主要飲料生產商已充分利用現有的分銷管道,並大力投資於改善情緒的產品線。即飲型產品省去了沖調時間,鼓勵消費者隨時隨地飲用。消費者對能量飲料和放鬆飲料的熟悉程度正在推動他們對改善情緒產品的接受度。
在預測期內,適應原產業預計將呈現最高的複合年成長率。
在預測期內,適應原產業預計將呈現最高的成長率,這主要得益於消費者對傳統草藥認知度的提高以及臨床對具有壓力調節功能的植物化合物日益成長的興趣。睡茄、紅景天和聖羅勒作為控制皮質醇水平和平衡情緒的有效天然替代品,正獲得廣泛認可。食品和飲料製造商正將適應原提取物添加到其不斷擴大的產品線中,從功能性咖啡到營養棒,不一而足。 「潔淨標示」趨勢傾向於使用易於識別的植物來源成分,而非合成替代品。主要市場的法律規範也在不斷發展,以適應傳統的植物來源健康聲明。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於消費者對機能性食品的高度認知以及對心理健康產品的強勁需求。美國在該領域處於領先地位,擁有成熟的適應原飲料和含益生菌的情緒支持產品市場。總部位於該地區的主要食品飲料公司正大力投資情緒改善相關的研發。直接面對消費者(D2C)的電子商務管道正在幫助創新機能性食品新創公司快速進入市場。消費者願意為經臨床驗證的情緒支持成分支付更高的價格,這推動了強勁的產生收入。
在預測期內,北美預計將呈現最高的複合年成長率,這主要得益於心理健康在企業健康計劃和雇主提供的食品補貼方案中日益普及。疫情後,職場對心理健康的重視推動了辦公環境中對功能性點心和飲料的需求。遠端醫療和數位療法平台推薦飲食療法作為傳統心理健康治療的輔助。對專注於神經營養的食品科技新創公司的投資正在提升該地區的創新能力。支持情緒相關成分「結構-功能標籤」的法規進展正在促進資訊向市場的傳播。
According to Stratistics MRC, the Global Mood Enhancement Functional Foods Market is accounted for $5.4 billion in 2026 and is expected to reach $10.0 billion by 2034 growing at a CAGR of 10.8% during the forecast period. Mood enhancement functional foods refer to food and beverage products formulated with bioactive ingredients that influence neurotransmitter activity, stress response pathways, and emotional regulation to support mental wellbeing. These products incorporate functional ingredients such as probiotics, adaptogens, omega-3 fatty acids, vitamins, minerals, botanical extracts, and amino acids that have demonstrated effects on serotonin, dopamine, and cortisol levels. They are designed for regular consumption as part of a daily diet and include functional beverages, nutrition bars, fortified dairy products, snacks, cereals, and confectionery items. Mood enhancement functional foods are developed based on clinical research linking specific nutrients and botanical compounds to measurable improvements in mood, stress resilience, cognitive function, and emotional balance.
Mental health awareness
The growing global recognition of mental health as a critical component of overall wellness is driving substantial demand for mood enhancement functional foods. Consumers are increasingly seeking non-pharmaceutical approaches to managing stress, anxiety, and mood fluctuations through dietary interventions. Scientific research validating the gut-brain axis connection has elevated interest in probiotic and prebiotic formulations targeting emotional wellbeing. Workplace wellness programs are incorporating functional food recommendations as part of holistic employee health initiatives. This cultural normalization of food-as-medicine approaches creates sustained market demand across demographic segments.
Efficacy skepticism
Consumer and healthcare professional skepticism regarding the efficacy of mood-enhancing food products presents a significant market restraint. Many consumers question whether functional ingredients in food matrices can deliver therapeutic doses comparable to supplements or medications. The placebo effect complicates the interpretation of consumer-reported benefits, undermining credibility. Regulatory frameworks in major markets restrict specific mood-related health claims, limiting marketing differentiation. These trust and communication challenges require brands to invest heavily in clinical substantiation and transparent ingredient disclosure.
Personalized nutrition platforms
The integration of mood enhancement functional foods with digital health platforms and personalized nutrition services presents transformative market expansion opportunities. Genetic testing and microbiome analysis can identify individual nutrient deficiencies affecting mood regulation, enabling targeted product recommendations. Mobile applications that track mood patterns alongside dietary intake create data-driven personalization opportunities. Subscription-based personalized functional food boxes tailored to stress profiles and emotional wellness goals command premium pricing. This convergence of food technology and digital health creates differentiated value propositions.
Regulatory claim restrictions
Stringent regulatory limitations on mood-related health claims for food products pose a significant threat to market communication and consumer education efforts. The U.S. Food and Drug Administration and European Food Safety Authority maintain strict boundaries between food and drug classifications, restricting claims about treating or preventing mental health conditions. Brands must navigate complex substantiation requirements for any implied mood benefits. Regulatory enforcement actions against non-compliant claims can result in product recalls and reputational damage. These constraints limit the ability of functional food manufacturers to effectively communicate product value.
The COVID-19 pandemic significantly elevated consumer interest in mood enhancement functional foods as populations experienced unprecedented stress, isolation, and anxiety. Lockdown periods disrupted supply chains for specialty functional ingredients, causing temporary product shortages. However, the crisis accelerated the adoption of food-based wellness routines as consumers sought accessible self-care strategies at home. Post-pandemic, the normalization of mental health conversations has created a structural shift toward proactive emotional wellbeing management through diet. The sustained focus on holistic wellness continues to drive innovation in mood-targeting formulations.
The functional beverages segment is expected to be the largest during the forecast period
The functional beverages segment is expected to account for the largest market share during the forecast period, due to the convenience of liquid delivery formats and the established consumer habit of beverage consumption throughout the day. Functional beverages allow for precise dosing of mood-enhancing ingredients such as adaptogens, L-theanine, and B-vitamins in palatable and portable formats. Major beverage manufacturers have invested heavily in mood-focused product lines, leveraging existing distribution infrastructure. The ready-to-drink format eliminates preparation barriers and supports on-the-go consumption patterns. Consumer familiarity with energy and relaxation beverages facilitates acceptance of mood enhancement positioning.
The adaptogens segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the adaptogens segment is predicted to witness the highest growth rate, driven by increasing consumer familiarity with traditional herbal medicines and growing clinical interest in stress-modulating botanical compounds. Ashwagandha, rhodiola, and holy basil are gaining mainstream recognition as effective natural alternatives for managing cortisol levels and promoting emotional equilibrium. Food and beverage manufacturers are incorporating adaptogen extracts into an expanding range of products from functional coffees to nutrition bars. The clean-label movement favors recognizable plant-based ingredients over synthetic alternatives. Regulatory frameworks in key markets are evolving to accommodate traditional botanical health claims.
During the forecast period, the North America region is expected to hold the largest market share, due to high consumer awareness of functional foods and strong demand for mental wellness products. The United States leads with an established market for adaptogenic beverages and probiotic mood-supporting formulations. Major food and beverage companies headquartered in the region are investing heavily in mood enhancement research and product development. Direct-to-consumer e-commerce channels facilitate rapid market entry for innovative functional food startups. Consumer willingness to pay premium prices for clinically validated mood-supporting ingredients supports robust revenue generation.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to accelerating integration of mental wellness into corporate wellness programs and employer-sponsored food benefit initiatives. The post-pandemic emphasis on workplace mental health is driving demand for functional snacks and beverages in office environments. Telehealth and digital therapy platforms are recommending dietary interventions as adjuncts to traditional mental health treatment. Investment in food technology startups focused on neuro-nutrition is expanding regional innovation capacity. Regulatory developments supporting structure-function claims for mood-related ingredients facilitate market communication.
Key players in the market
Some of the key players in Mood Enhancement Functional Foods Market include Nestle S.A., Danone S.A., PepsiCo, Inc., The Coca-Cola Company, Kellogg Company, General Mills, Inc., Arla Foods amba, Yakult Honsha Co., Ltd., Mondelez International, Inc., Unilever PLC, Glanbia plc, Kerry Group plc, Herbalife Ltd., Abbott Laboratories, Amway Corporation, DSM-Firmenich AG and Ajinomoto Co., Inc..
In June 2026, Nestle S.A. launched a mood-supporting functional beverage line containing clinically validated adaptogen blends targeting stress reduction for working professionals.
In May 2026, Danone S.A. expanded its probiotic yogurt portfolio with psychobiotic strains specifically selected for their demonstrated impact on anxiety and mood regulation pathways.
In April 2026, PepsiCo, Inc. introduced a functional sparkling water infused with L-theanine and botanical extracts designed to promote relaxation without drowsiness across North American markets.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.